title: Quantum chemical analysis of MHC-peptide interactions for vaccine design.
abstract: The development of an adequate immune response against pathogens is mediated by molecular interactions between different cell types. Among them, binding of antigenic peptides to the Major Histocompatibility Complex (MHC) molecule expressed on the membrane of antigen presenting cells (APCs), and their subsequent recognition by the T cell receptor have been demonstrated to be crucial for developing an adequate immune response. The present review compiles computational quantum chemistry studies about the electrostatic potential variations induced on the MHC binding region by peptide's amino acids, carried out with the aim of describing MHC-peptide binding interactions. The global idea is that the electrostatic potential can be represented in terms of a series expansion (charge, dipole, quadrupole, hexadecapole, etc.) whose three first terms provide a good local approximation to the molecular electrostatic 'landscape' and to the variations induced on such landscape by targeted modifications on the residues of the antigenic peptide. Studies carried out in four MHC class II human allele molecules, which are the most representative alleles of their corresponding haplotypes, showed that each of these molecules have conserved as well as specific electrostatic characteristics, which can be correlated at a good extent with the peptide binding profiles reported experimentally for these molecules. The information provided by such characteristics would help increase our knowledge about antigen binding and presentation, and could ultimately contribute to developing a logical and rational methodology for designing chemically synthesized, multi-antigenic, subunit-based vaccines, through the application of quantum chemistry methods.
authors.affiliation: Fundación Instituto de Immunología de Colombia, Carrera 50 No. 26-20, Bogotá DC, Colombia.
authors.forename: W A
authors.initials: WA
authors.lastname: Agudelo
authors.forename: M E
authors.initials: ME
authors.lastname: Patarroyo
mesh_terms: D006680:HLA Antigens / Q000737:chemistry; D006649:Histocompatibility Antigens / Q000737:chemistry*; D006801:Humans; D010455:Peptides / Q000737:chemistry* / Q000276:immunology; D011485:Protein Binding; D011789:Quantum Theory; D055672:Static Electricity; D014612:Vaccines / Q000737:chemistry* / Q000276:immunology
chemical_list: D006680:HLA Antigens; D006649:Histocompatibility Antigens; D010455:Peptides; D014612:Vaccines
references.citation: Biochimie. 2006 Sep;88(9):1307-11
references.pmid: 16872734
references.citation: EMBO J. 1990 Jun;9(6):1797-803
references.pmid: 2189723
references.citation: Biochem Biophys Res Commun. 2004 Oct 29;323(4):1265-77
references.pmid: 15451434
references.citation: Chem Rev. 2008 Sep;108(9):3656-705
references.pmid: 18710292
references.citation: J Cell Mol Med. 2008 Oct;12(5B):1915-35
references.pmid: 19012725
references.citation: J Pharmacol Sci. 2007 Dec;105(4):299-316
references.pmid: 18094522
references.citation: J Phys Chem A. 2009 Oct 1;113(39):10527-33
references.pmid: 19775172
references.citation: Brief Bioinform. 2007 Mar;8(2):96-108
references.pmid: 17077136
references.citation: J Exp Med. 1998 Oct 19;188(8):1511-20
references.pmid: 9782128
references.citation: J Phys Chem A. 2007 Nov 1;111(43):11134-40
references.pmid: 17918915
references.citation: Bioinformatics. 2006 Jul 15;22(14):e16-24
references.pmid: 16873467
references.citation: Immunity. 1997 Oct;7(4):473-81
references.pmid: 9354468
references.citation: J Mol Graph. 1996 Feb;14(1):33-8, 27-8
references.pmid: 8744570
references.citation: Acc Chem Res. 2008 Mar;41(3):377-86
references.pmid: 18266328
references.citation: J Med Chem. 2001 Oct 25;44(22):3572-81
references.pmid: 11606121
references.citation: Nature. 1993 Jul 1;364(6432):33-9
references.pmid: 8316295
references.citation: Nature. 1994 Mar 17;368(6468):215-21
references.pmid: 8145819
references.citation: Methods. 2004 Dec;34(4):436-43
references.pmid: 15542369
references.citation: J Exp Med. 2002 Mar 4;195(5):571-81
references.pmid: 11877480
references.citation: Curr Med Chem. 2005;12(24):2849-65
references.pmid: 16305475
references.citation: Med Chem. 2008 May;4(3):278-92
references.pmid: 18473921
references.citation: Immunogenetics. 2004 Mar;55(12):797-810
references.pmid: 14963618
references.citation: Biochem Biophys Res Commun. 2005 May 20;330(4):1162-7
references.pmid: 15823565
references.citation: Nature. 1995 Nov 30;378(6556):457-62
references.pmid: 7477400